Table 2

Clinical characteristics and plasma CCL3 and CCL4 concentrations in EBV-positive immunocompromised patients

Patient no.Age (yr)/genderaDiagnosisConcn (pg/ml)
CCL3CCL4
15/MHemophagocytotic syndrome50.0136.8
215/MBone marrow transplantation16.643.8
33/FLiver transplantation39.4158.1
44/FLiver transplantation10.075.5
55/FLiver transplantation67.550.5
619/MBone marrow transplantation144.6230.9
715/MLymphoproliferative disorder38.6147.3
818/FLiver transplantation28.323.1
99/FBone marrow transplantation13.383.1
106/MLiver transplantation15.0174.4
115/FLiver transplantation76.1173.1
1210/MLymphoproliferative disorder44.6110.9
Avg45.3117.3
  • a M, male; F, female.